BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3435885)

  • 1. Personality patterns and duodenal ulcer relapse under antisecretory treatment.
    Magni G; Di Mario F; Conlon P; Naccarato R
    Can J Psychiatry; 1987 Dec; 32(9):777-8. PubMed ID: 3435885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personality and duodenal ulcer response to antisecretory treatment.
    Magni G; Di Mario F; Borgherini G; Donzella G; Battaglia G; Pellegrini C
    Digestion; 1987; 38(3):152-5. PubMed ID: 3443224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personality profiles of patients with duodenal ulcer.
    Magni G; Di Mario F; Rizzardo R; Pulin S; Naccarato R
    Am J Psychiatry; 1986 Oct; 143(10):1297-300. PubMed ID: 3766795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The personality characteristics of patients with duodenal peptic ulcer].
    Buglak NP; Alekseĭchuk AM; Nazarova LS; Levchenko MV
    Lik Sprava; 1997; (2):79-82. PubMed ID: 9333492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of duodenal ulcer under continuous antisecretory treatment: an approach to the detection of predictive markers.
    Battaglia G; Farini R; Di Mario F; Piccoli A; Plebani M; Vianello F; Burlina A; Naccarato R
    Am J Gastroenterol; 1984 Nov; 79(11):831-4. PubMed ID: 6095649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The personality pattern of patients with chronic peptic ulcer. A case-control study.
    McIntosh JH; Nasiry RW; Frydman M; Waller SL; Piper DW
    Scand J Gastroenterol; 1983 Oct; 18(7):945-50. PubMed ID: 6676928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous maintenance with low-dose lansoprazole versus Helicobacter pylori eradication in the prevention of duodenal ulcer recurrence.
    Parente F; Bargiggia S; Bollani S; Colombo E; Bianchi Porro G
    Hepatogastroenterology; 1998; 45(22):990-3. PubMed ID: 9755995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personality factors in chronic gastric and duodenal ulcers: a controlled study.
    Magni G; Di Mario F; Trinciarelli G; Borgherini G; Silvestri A
    Gastroenterol Clin Biol; 1988 Dec; 12(12):926-30. PubMed ID: 3069548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The personality pattern of duodenal ulcer patients in relation to spontaneous ulcer healing and relapse.
    Jess P; von der Lieth L; Matzen P; Madsen P; Krag E; Knigge U; Højgaard L; Dejgård A; Christiansen PM; Bonnevie O
    J Intern Med; 1989 Dec; 226(6):395-400. PubMed ID: 2489224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced relapse rate in duodenal ulcer disease leads to normalization of psychological distress: twelve-year follow-up.
    Wilhelmsen I; Berstad A
    Scand J Gastroenterol; 2004 Aug; 39(8):717-21. PubMed ID: 15513354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term treatment of duodenal ulcer with pirenzepine.
    Cheli R; Giacosa A; Molinari F
    Scand J Gastroenterol Suppl; 1982; 72():221-4. PubMed ID: 6957992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hostile personality characteristics of duodenal ulcer patients.
    Rubino IA; Castiglia I; Rossi P; Paoluzi P
    Ital J Gastroenterol; 1990 Dec; 22(6):338-41. PubMed ID: 2131951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum gastrin and the family environment in duodenal ulcer disease.
    Wolcott DL; Wellisch DK; Robertson CR; Arthur RJ
    Psychosom Med; 1981 Dec; 43(6):501-7. PubMed ID: 6976585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinico-endoscopic, psychological and physical characteristics of duodenal peptic ulcer patients using piracetam and aevit].
    Pimenov LT; Balobanov VIu; Pushina LN; Shemiakina TV
    Ter Arkh; 1997; 69(2):10-3. PubMed ID: 9173565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking does not contribute to duodenal ulcer relapse after Helicobacter pylori eradication.
    Borody TJ; George LL; Brandl S; Andrews P; Jankiewicz E; Ostapowicz N
    Am J Gastroenterol; 1992 Oct; 87(10):1390-3. PubMed ID: 1415092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of different strategies for treating duodenal ulcer. Helicobacter pylori eradication versus antisecretory treatment.
    Badia X; Segú JL; Ollé A; Brosa M; Monés J; García Ponte L
    Pharmacoeconomics; 1997 Apr; 11(4):367-76. PubMed ID: 10166411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance therapy with colloidal bismuth subcitrate reduces duodenal ulcer relapse.
    Bardhan KD; Singh S; Morris P; Thompson M; Hinchliffe RF; Cary BA; Wall RM; Blakemore CB
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):128-34. PubMed ID: 9646192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Piracetam in combined pathogenetic therapy of recurrent duodenal ulcer].
    Tsimmerman IaS; Shchetkin DI
    Klin Med (Mosk); 2002; 80(1):48-53. PubMed ID: 11855320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic management of duodenal ulcer except in emergency cases: antisecretory treatment].
    Ruszniewski P
    Gastroenterol Clin Biol; 1996 Jan; 20(1 Pt 2):S53-S57. PubMed ID: 8734371
    [No Abstract]   [Full Text] [Related]  

  • 20. The personality patterns in patients with duodenal ulcer and ulcer-like dyspepsia and their relationship to the course of the diseases. Hvidovre Ulcer Project Group.
    Jess P; Eldrup J
    J Intern Med; 1994 Jun; 235(6):589-94. PubMed ID: 8207365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.